INDEMNITY AGREEMENTIndemnity Agreement • May 1st, 2014 • Proteinsimple • Laboratory analytical instruments • Delaware
Contract Type FiledMay 1st, 2014 Company Industry JurisdictionTHIS INDEMNITY AGREEMENT (the “Agreement”) is made and entered into as of , 2014, between ProteinSimple, a Delaware corporation (the “Company”), and (“Indemnitee”).
PROTEINSIMPLE EARLY EXERCISE STOCK PURCHASE AGREEMENT UNDER THE 2013 EQUITY INCENTIVE PLANEarly Exercise Stock Purchase Agreement • March 27th, 2014 • Proteinsimple • Laboratory analytical instruments • California
Contract Type FiledMarch 27th, 2014 Company Industry JurisdictionWHEREAS, Purchaser holds a stock option dated to purchase shares of common stock (“Common Stock”) of the Company (the “Option”) pursuant to the Company’s 2013 Equity Incentive Plan (the “Plan”); and
NET LEASE AGREEMENT (Multi-Tenant) by and between CELL BIOSCIENCES, INC., a Delaware corporation (“Tenant”) and 702/703 INVESTORS, LLC, a Delaware limited liability company (“Landlord”)Net Lease Agreement • March 27th, 2014 • Proteinsimple • Laboratory analytical instruments • California
Contract Type FiledMarch 27th, 2014 Company Industry JurisdictionFor and in consideration of the rentals, covenants, and conditions hereinafter set forth, Landlord hereby leases to Tenant, and Tenant hereby rents from Landlord, the following described Premises for the term, at the rental and subject to and upon all of the terms, covenants and agreements set forth in this Net Lease Agreement (“Lease”):
CELL BIOSCIENCES, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT October 19, 2010Investors’ Rights Agreement • March 27th, 2014 • Proteinsimple • Laboratory analytical instruments • California
Contract Type FiledMarch 27th, 2014 Company Industry JurisdictionThis Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of the 19th day of October, 2010, by and among Cell Biosciences, Inc., a Delaware corporation (the “Company”), and the holders of the Company’s Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and/or Series F Preferred Stock listed on Schedule A attached hereto (each an “Investor” and together, the “Investors”).
THIRD AMENDMENT TO FIRST AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 1st, 2014 • Proteinsimple • Laboratory analytical instruments
Contract Type FiledMay 1st, 2014 Company IndustryThis Third Amendment to First Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into by and between PROTEINSIMPLE, a Delaware corporation (f/k/a Cell Biosciences, Inc., a Delaware corporation) (“ProteinSimple”), PROTEINSIMPLE LTD., an Ontario corporation (successor by amalgamation to BRIGHTWELL TECHNOLOGIES INC. and PROTEINSIMPLE LTD.) (“ProteinSimple Canada” and together with ProteinSimple, collectively, the “Borrower”) and COMERICA BANK (“Bank”) as of this 19th day of February, 2013.
FIRST AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT BY AND AMONG PROTEINSIMPLE PROTEINSIMPLE LTD. AND COMERICA BANK DATED JANUARY 26, 2012Loan and Security Agreement • March 27th, 2014 • Proteinsimple • Laboratory analytical instruments • California
Contract Type FiledMarch 27th, 2014 Company Industry JurisdictionThis FIRST AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT is entered into as of January 26, 2012, by and among COMERICA BANK, a Texas banking association (“Bank”), PROTEINSIMPLE, a Delaware corporation (formerly known as Cell Biosciences, Inc.) (“ProteinSimple”) and PROTEINSIMPLE LTD., an Ontario corporation (successor by amalgamation to BRIGHTWELL TECHNOLOGIES INC. and PROTEINSIMPLE LTD.) (“ProteinSimple Canada”, and together with ProteinSimple, the “Borrowers”).
CELL BIOSCIENCES, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT for Tim HarknessExecutive Employment Agreement • March 27th, 2014 • Proteinsimple • Laboratory analytical instruments • California
Contract Type FiledMarch 27th, 2014 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement (the “Agreement”), made between Cell Biosciences, Inc. (the “Company”) and Tim Harkness (the “Executive”) (collectively, the “Parties”), amends, restates and supersedes in its entirety the employment offer letter agreement between the Company and Executive that was effective as of June 12, 2008 (the “Original Agreement”). This Agreement is effective as of February 3, 2011.
SECOND AMENDMENT TO FIRST AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 1st, 2014 • Proteinsimple • Laboratory analytical instruments
Contract Type FiledMay 1st, 2014 Company IndustryThis Second Amendment to First Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into by and between PROTEINSIMPLE, a Delaware corporation (f/k/a Cell Biosciences, Inc., a Delaware corporation) (“ProteinSimple”), PROTEINSIMPLE LTD., an Ontario corporation (successor by amalgamation to BRIGHTWELL TECHNOLOGIES INC. and PROTEINSIMPLE LTD.) (“ProteinSimple Canada” and together with ProteinSimple, collectively, the “Borrower”) and COMERICA BANK (“Bank”) as of this 7 day of November, 2012.
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 1st, 2014 • Proteinsimple • Laboratory analytical instruments
Contract Type FiledMay 1st, 2014 Company IndustryThis First Amendment to Loan and Security Agreement (this “Amendment”) is entered into by and between PROTEINSIMPLE, a Delaware corporation (f/k/a Cell Biosciences, Inc., a Delaware corporation) (“ProteinSimple”), PROTEINSIMPLE LTD., an Ontario corporation (successor by amalgamation to BRIGHTWELL TECHNOLOGIES INC. and PROTEINSIMPLE LTD.) (“ProteinSimple Canada” and together with ProteinSimple, collectively, the “Borrower”) and COMERICA BANK (“Bank”) as of this 31st day of May, 2012.
FOURTH AMENDMENT TO FIRST AMENDED AND RESTATED LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 1st, 2014 • Proteinsimple • Laboratory analytical instruments
Contract Type FiledMay 1st, 2014 Company IndustryThis Fourth Amendment to First Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into by and between PROTEINSIMPLE, a Delaware corporation (f/k/a Cell Biosciences, Inc., a Delaware corporation) (“ProteinSimple”), PROTEINSIMPLE LTD., an Ontario corporation (successor by amalgamation to BRIGHTWELL TECHNOLOGIES INC. and PROTEINSIMPLE LTD.) (“ProteinSimple Canada” and together with ProteinSimple, collectively, the “Borrower”) and COMERICA BANK (“Bank”) as of this 18th day of March, 2014.